Located on the 4th floor of the Hotel New Otani Kioicho Building in Kioicho, Chiyoda-ku, Tokyo, Medical Corporation ICVS Tokyo Clinic specializes in cancer immunotherapy. Established in 2008 by Dr. Kenichiro Hasumi, who has been engaged in cancer immunotherapy research and clinical treatment both domestically and internationally, the clinic offers "HITV therapy (Human Initiated Therapeutic Vaccine)" specifically designed for Stage IV advanced and recurrent cancers. This next-generation immunotherapy utilizes dendritic cells, which play a central role in the immune system, to transmit information to killer T cells that attack cancer cells, aiming for cancer elimination. A distinctive feature of the clinic is the "CT-guided administration" technique, which uses real-time CT imaging to directly inject dendritic cells into tumors. The facility is also equipped with a Cell Processing Center (CPC) compliant with international GMP standards, where dedicated cell culture specialists manage and process high-quality dendritic cells. The clinic is open on weekdays from 9:00 AM to 5:00 PM, accepts credit cards and electronic payments, and offers barrier-free facilities.